The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Bioniche Signs Urocidin Deal with Endo Pharmaceuticals: $20 Million Up Front, $110 Million plus Supply to Follow

Exciting deal! Since Rick and I worked on this one, let me just turn it over to the press release:

Bioniche Life Sciences Inc. (TSX: BNC) and Endo Pharmaceuticals (Nasdaq: ENDP) jointly announced today that Endo has licensed from Bioniche the exclusive rights to develop and market Urocidin™ in the U.S. with an option for global rights. Urocidin is a patented formulation of Mycobacterial Cell Wall-DNA Complex (MCC) developed by Bioniche for the treatment of non-muscle-invasive bladder cancer that is currently undergoing Phase III clinical testing. Under the agreement signed by both companies, Endo will pay Bioniche an up-front cash payment of $20M USD and the potential for up to $110M USD in additional payments linked to the achievement of future clinical, regulatory, and commercial milestones. In addition, Bioniche will manufacture the product and receive a transfer price for supply.

Update: Here it is on FierceBiotech.

Update 2: Here’s the BIO SmartBrief post.

Share Button

About these ads

4 responses to “Bioniche Signs Urocidin Deal with Endo Pharmaceuticals: $20 Million Up Front, $110 Million plus Supply to Follow

  1. Pingback: Monday Deal Review: July 12, 2009 « The Cross-Border Biotech Blog

  2. Pingback: New Data Shows 70% of Canada’s Biotech Companies Have Under 12 Months’ Cash. BIOTECanada’s New Ask: Government Loans. « The Cross-Border Biotech Blog

  3. Pingback: Monday Biotech Deal Review: February 15, 2010 « The Cross-Border Biotech Blog

  4. Pingback: Biotech Trends Update — IP Constituencies: Endo’s Qualitest Purchase Shows Full Integration of Innovator and Generic Strategies | The Cross-Border Biotech Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 129 other followers